SURTECO SE (SUR) | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
SURTECO SE

BRIEF

published on 04/30/2024 at 07:05, 6 months 21 days ago

SURTECO GROUP SE Reports Strong Start to 2024

EBITDA Increase SURTECO GROUP SE Q1 Financial Performance 2024 Annual Sales Forecast Performance Plus Programme
PRESS RELEASE

published on 04/30/2024 at 07:00, 6 months 21 days ago

SURTECO GROUP SE: Good start to the year 2024
SURTECO GROUP SE reports a positive start to 2024 with EBITDA up 44% and net profit up 90%. Sales increase by 8% to €222.3 million in Q1-2024

Financial Performance Sales Growth Earnings SURTECO GROUP SE Q1-2024
BRIEF

published on 04/24/2024 at 07:10, 6 months 27 days ago

SURTECO GROUP SE Reports Mixed Financial Results for 2023 and Positive Outlook for 2024

Financial Performance 2024 Outlook EBITDA Increase Annual Report 2023 SURTECO GROUP SE
PRESS RELEASE

published on 04/24/2024 at 07:05, 6 months 27 days ago

SURTECO GROUP SE: Good start to the business year 2024 after a difficult year in 2023
SURTECO GROUP SE reports a good start to the business year 2024 following a challenging year in 2023. Earnings and sales projections for 2024 provided

Financial Report Earnings Sales Projections SURTECO GROUP SE Business Year 2024
BRIEF

published on 04/03/2024 at 18:05, 7 months 17 days ago

SURTECO Expands in the United Kingdom with Strategic Acquisitions

Growth Strategy Acquisition United Kingdom SURTECO Profiles Business
PRESS RELEASE

published on 04/03/2024 at 18:00, 7 months 17 days ago

SURTECO expands in United Kingdom
SURTECO GROUP SE acquires extrusion specialists in the UK to strengthen market position in profile business and drive growth. Purchase agreement signed in low single-digit million range

Acquisition Growth United Kingdom SURTECO GROUP SE Profile Business
BRIEF

published on 03/26/2024 at 08:27, 7 months 26 days ago

SURTECO GROUP SE Reports Preliminary Financial Results for 2023

EBITDA Preliminary Financial Results 2023 Financial Performance Omnova Acquisition SURTECO GROUP SE
PRESS RELEASE

published on 03/26/2024 at 08:22, 7 months 26 days ago

Correction of a release from 25/03/2024, 17:30 CET/CEST - SURTECO GROUP SE: Preliminary result for the business year 2023
SURTECO GROUP SE reports preliminary results for the business year 2023, with consolidated net sales of €835.1 million and EBITDA of €66.6 million. Details on integration of Omnova divisions and future outlook shared

EBITDA Preliminary Results Business Year 2023 SURTECO GROUP SE Omnova Divisions
BRIEF

published on 03/25/2024 at 17:35, 7 months 26 days ago

SURTECO GROUP SE Reports Preliminary Results for 2023

EBITDA Financial Performance Preliminary Results SURTECO Omnova Acquisition
PRESS RELEASE

published on 03/25/2024 at 17:30, 7 months 26 days ago

SURTECO GROUP SE: Preliminary result for the business year 2023
SURTECO GROUP SE reported unaudited preliminary results for the business year 2023, including a consolidated net profit of €835.1 million. Despite challenges, the company achieved adjusted EBITDA of €86.4 million

EBITDA Financial Performance Preliminary Results Business Year 2023 SURTECO GROUP SE

Accesswire

Published on 11/21/2024 at 13:30, 25 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 25 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 55 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 55 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 55 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 39 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 19 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 40 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 48 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 55 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 57 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 35 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 10 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 10 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE